The Global Mental Health (GMH) movement aims to provide urgently needed treatment to
those with mental illness, especially in low-and middle-income countries. Due to the …

Introduction There has been increasing interest in the role psilocybin may play in the
treatment of depressive disorders. Several clinical trials have shown psilocybin to have …

The resurgence of interest in the therapeutic potential of psychedelics for treating psychiatric
disorders has rekindled efforts to elucidate their mechanism of action. In this Perspective, we …

Background: Psychedelics are able to acutely alter emotional reactivity and self-
consciousness. However, whether the regular naturalistic use of psychedelics can be linked …

There is a need to understand ways in which Asians in North America attempt to heal from
racial trauma, given their well-documented high risk of exposure and associated adverse …

A major impediment to any nation abandoning the policy of drug prohibition has been the
fact that international drug treaties to which the majority of United Nations (UN) member …

Après des années d'interdiction, les recherches scientifiques et universitaires sur les
drogues psychodysleptiques ont repris en Occident. Parallèlement, on permet aux cliniciens …

Psilocybin is a classic psychedelic drug that has attracted increasing research interest over
the past 10 years as a possible treatment for mood, anxiety and related conditions. Initial …

Mescaline derivative (2C phenethylamines) drugs have been modified by the introduction of
a N-2-methoxybenzyl group to originate a new series of compounds with recognized and …

Background Few studies have assessed the epidemiology of hallucinogenic substance use
among racial and ethnic groups of varying age cohorts. Use of psychedelic substances may …